These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7656219)
1. Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist. Hsieh TC; Chiao JW Cancer Lett; 1995 Aug; 95(1-2):119-23. PubMed ID: 7656219 [TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma. Louie S; Cai J; Law R; Lin G; Lunardi-Iskandar Y; Jung B; Masood R; Gill P J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):455-60. PubMed ID: 7697441 [TBL] [Abstract][Full Text] [Related]
3. Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1 alpha and IL-1 receptor antagonist. Phillips WG; Feldmann M; Breathnach SM; Brennan FM Clin Exp Immunol; 1995 Jul; 101(1):177-82. PubMed ID: 7621586 [TBL] [Abstract][Full Text] [Related]
4. Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity. Greenfeder SA; Varnell T; Powers G; Lombard-Gillooly K; Shuster D; McIntyre KW; Ryan DE; Levin W; Madison V; Ju G J Biol Chem; 1995 Sep; 270(38):22460-6. PubMed ID: 7673234 [TBL] [Abstract][Full Text] [Related]
5. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1. Oelmann E; Kraemer A; Serve H; Reufi B; Oberberg D; Patt S; Herbst H; Stein H; Thiel E; Berdel WE Int J Cancer; 1997 Jun; 71(6):1066-76. PubMed ID: 9185713 [TBL] [Abstract][Full Text] [Related]
6. Human recombinant interleukin-1 receptor antagonist blocks bone resorption induced by interleukin-1 beta but not interleukin-1 alpha. Chole RA; Tinling SP; Faddis BT Calcif Tissue Int; 1994 Jul; 55(1):12-5. PubMed ID: 7922783 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor. Loscher CE; Mills KH; Lynch MA J Neuroimmunol; 2003 Apr; 137(1-2):117-24. PubMed ID: 12667655 [TBL] [Abstract][Full Text] [Related]
8. An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma. Lu ZY; Bataille R; Poubelle P; Rapp MJ; Harousseau JL; Klein B Stem Cells; 1995 Aug; 13 Suppl 2():28-34. PubMed ID: 8520508 [TBL] [Abstract][Full Text] [Related]
10. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Swiergiel AH; Smagin GN; Johnson LJ; Dunn AJ Brain Res; 1997 Nov; 776(1-2):96-104. PubMed ID: 9439800 [TBL] [Abstract][Full Text] [Related]
11. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells. Gabay C; Genin B; Mentha G; Iynedjian PB; Roux-Lombard P; Guerne PA Clin Exp Immunol; 1995 May; 100(2):306-13. PubMed ID: 7743670 [TBL] [Abstract][Full Text] [Related]
12. The ovarian action of interleukin-1 is receptor mediated: reversal by a naturally occurring interleukin-1 receptor antagonist. Kokia E; Ben-Shlomo I; Adashi EY Fertil Steril; 1995 Jan; 63(1):176-81. PubMed ID: 7805908 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133 [TBL] [Abstract][Full Text] [Related]
14. Characterization of an interleukin 1 receptor antagonist protein released from ultraviolet-irradiated epidermal sheet. Hirao T; Aoki H; Ichikawa H; Sato Y J Dermatol Sci; 1997 Mar; 14(3):189-98. PubMed ID: 9138476 [TBL] [Abstract][Full Text] [Related]
15. The effects of interleukin-1beta (IL-1beta) on human thyrocyte functions are counteracted by the IL-1 receptor antagonist. Rasmussen AK; Diamant M; Blichert-Toft M; Bendtzen K; Feldt-Rasmussen U Endocrinology; 1997 May; 138(5):2043-8. PubMed ID: 9112403 [TBL] [Abstract][Full Text] [Related]
16. Preferential production of interleukin-1 beta over interleukin-1 receptor antagonist contributes to proliferation and suppression of apoptosis in leukemic cells. Furukawa Y; Kikuchi J; Terui Y; Kitagawa S; Ohta M; Miura Y; Saito M Jpn J Cancer Res; 1995 Feb; 86(2):208-16. PubMed ID: 7730146 [TBL] [Abstract][Full Text] [Related]
17. Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production. Welsh N; Bendtzen K; Welsh M J Clin Invest; 1995 Apr; 95(4):1717-22. PubMed ID: 7706480 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of endotoxin on LH secretion in the ovariectomized monkey are prevented by naloxone but not by an interleukin-1 receptor antagonist. Xiao E; Xia-Zhang L; Ferin M Neuroimmunomodulation; 2000; 7(1):6-15. PubMed ID: 10601814 [TBL] [Abstract][Full Text] [Related]